What vaccine? When? … Government “negotiating with 5 companies”



[ad_1]

◀ Anchor ▶

In addition to Pfizer and Modena, other pharmaceutical companies are expected to advertise more and more.

The government is meticulously analyzing which vaccine is safest and most effective.

He is currently in the process of negotiating the purchase of five products and the goal is to get vaccinated before the flu shot next fall.

Then reporter Shin Jeong-yeon reports.

◀ Report ▶

The Modena vaccine was developed on the basis of mRNA, the so-called “messenger ribonucleic acid” technology.

It is the same as the Pfizer vaccine released last week.

Both vaccines produce antibodies by injecting the corona19 genetic material, mRNA, into the body, which is easy to manufacture and reduces development time.

However, compared to the Pfizer vaccine, which must be kept at a very low temperature, a modder or vaccine that can be stored in a general refrigerator is expected to further reduce distribution costs.

The easiest to store is a traditional vaccine that weakens the toxicity of the corona virus 19, which is the cause of the disease, such as the influenza vaccine or the Japanese encephalitis vaccine.

Sinobag and Sinoparm of China are in phase 3 clinical trials.

However, many point out that further verification is needed to ensure you have security that meets international standards.

The most attractive by price is AstraZeneca.

The cost of a dose is expected to be around 4,400 won, which is much cheaper than a modder or a vaccine that costs around 40,000 won or a Pfizer vaccine that costs around 21,000 won.

Currently, 10 vaccines abroad have entered phase 3 clinical trials …

The Korean government selected five of them to enter the purchase negotiations for safety and effectiveness.

These include Pfizer and Modena, who recently announced positive results.

[권준욱/중앙방역대책본부 제2부본부장]
“Among the five, the opinions of the advisory committee have been gathered on the need for pre-purchase efforts by making pre-purchases and buying late.”

In particular, it was revealed that the first decision was made on which pharmaceutical company to select for the guaranteed amount through the international organization for the joint purchase of vaccines, ‘Covax Facility’.

Our goal is to vaccinate patients with the corona19 vaccine prior to influenza vaccination in late fall of next year.

Quarantine authorities plan to announce which drug companies signed up and how much they have insured next week.

This is Jeongyeon Shin from MBC News.

(Video editing: Yurim Oh)

MBC News is waiting for your report 24 hours a day.

▷ Telephone 02-784-4000

▷ Email [email protected]

▷ Report from KakaoTalk @mbc

[ad_2]